Cold storage warehouses differ from traditional warehouses due to their superior refrigeration systems, insulation and strict ...

Q2 2025 Earnings Call Transcript July 31, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

The mean of analysts' price targets for Kiniksa Pharmaceuticals International, plc (KNSA) points to a 36% upside in the stock. While this highly sought-after metric has not proven reasonably effective ...

Indian drugmaker Mankind Pharma reported a lower first-quarter profit on Thursday, as mounting expenses outpaced strong ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

Dr. Fidelis Ayebae has left his role as the Managing Director and Chief Executive Officer of Fidson Healthcare Plc after ...

In this week's newsletter, read all about Forbes India's coverage of US President Donald Trump's 25 percent tariff ...

Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual ...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.16 EPS, expectations were $0 ...

Global cannabis policy must evolve using existing regulatory lanes—balancing public health, economics, and market growth without reinventing the wheel.